The Foundation for Sarcoidosis Research (FSR) and the American Thoracic Society (ATS) are pleased to announce that Mark Mallozzi, MD, MPH has been selected to receive the 2025 ATS/FSR Partner Grant, awarded to support innovative research in sarcoidosis and advance...
In May, the FSR team came together in San Francisco, California for the 2025 American Thoracic Society (ATS) International conference. ATS is one of our favorite events that takes place every year and brings together health care professionals, industry partners,...
In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change – Paid Time Off (PTO) Initiative, a national effort to reduce job-related barriers to clinical trial...
Sarcoidosis Awareness Month is a time for the community to rally together sharing stories, spreading awareness, and providing education about sarcoidosis to those all around the world. This year’s theme of #FacingSarcoidosisTogether truly captures the essence of...
The Foundation for Sarcoidosis Research (FSR) has awarded three pilot grants in the amount of $100,000 each, to Dr. Satish Sati from the University of Pennsylvania, Dr. Claire Rice from the University of Bristol, and Dr. Shaikh Muhammad Atif from the University of...
Foundation for Sarcoidosis Research Warns of Increased Risk of Sarcoidosis from Fire and Smoke Exposure Urging Immediate Action to Prevent Future Health Consequences 9/11 First Responders Serve as a Warning for the Long-Term Health Effects of Smoke Inhalation and...
We understand that living with sarcoidosis can be challenging, and many of you are constantly seeking new treatment options. We want to share an important update regarding recently announced results from a pulmonary sarcoidosis clinical trial. Key Points: Trial...
The Foundation for Sarcoidosis Research (FSR) is proud to announce the recipients of the 2024 FSR Cardiac Sarcoidosis Grant, providing $200,000 in funding to advance groundbreaking research aimed at improving the diagnosis, management, and treatment of cardiac...
In August of 2023, the Foundation for Sarcoidosis Research (FSR) submitted a Request for Opinion Letter on Clinical Trials and the Family and Medical Leave Act (FMLA) with the U.S. Department of Labor (DOL). On November 8, 2024, FSR received a letter of clarification...
The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, is pleased to announce the appointment of fourteen new members to serve the organization’s...
